Literature DB >> 18402996

Ultrastructural damage to heart tissue from repeated oral exposure to yessotoxin resolves in 3 months.

A Tubaro1, A Giangaspero, M Ardizzone, M R Soranzo, F Vita, T Yasumoto, J M Maucher, J S Ramsdell, S Sosa.   

Abstract

Yessotoxin (YTX), an algal toxin contaminating edible shellfish, was previously shown to induce ultrastructural changes in some cardiac muscle cells of mice after acute (1 and 2mg/kg) or daily repeated oral exposure (1 and 2mg/kg/day, for 7 days). Therefore, the temporal evolution of the ultrastructural myocardial alterations and the development of other signs of toxicity induced by a repeated daily oral administration of YTX (1mg/kg/day, for 7 days) to mice were evaluated within 3 months after the treatment. Symptoms, food consumption, body weight, gross pathology and histopathology of the main organs and tissues were observed, and plasma levels of transaminases, lactate dehydrogenase, creatinine and creatinine phosphokinase were measured. Heart, liver, kidneys and cerebellum were also analysed by transmission electron microscopy. In addition, the blood concentration of YTX was determined by a direct enzyme linked immunosorbent assay (ELISA) 24h after the last toxin administration. No mortality or other treatment-related changes, including histological or hematoclinical parameters, were recorded in mice administered with YTX. Similarly, electron microscopy did not reveal any ultrastructural alteration in the liver, kidneys, and cerebellum associated with YTX treatment. In contrast, changes in cardiac muscle cells near to the capillaries (clusters of rounded mitochondria and disorganization of myofibrils) were observed 24h after the treatment. These changes were also noted 30 days after the toxin administration, while after 90 days no differences in cardiac muscle cells between control and YTX-treated mice were observed, which indicated a recovery of the ultrastructural alterations induced by the toxin.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18402996     DOI: 10.1016/j.toxicon.2008.02.011

Source DB:  PubMed          Journal:  Toxicon        ISSN: 0041-0101            Impact factor:   3.033


  8 in total

1.  Yessotoxin determination in Mytilus galloprovincialis revealed by an in vitro functional assay.

Authors:  Maria Schirone; Pierina Visciano; Mirella Luciani; Antonella Ciarelli; Miriam Berti; Rosanna Tofalo; Giovanna Suzzi
Journal:  Environ Sci Pollut Res Int       Date:  2012-09-30       Impact factor: 4.223

2.  Acute cardiotoxicity evaluation of the marine biotoxins OA, DTX-1 and YTX.

Authors:  Sara F Ferreiro; Cristina Carrera; Natalia Vilariño; M Carmen Louzao; Germán Santamarina; Antonio G Cantalapiedra; Luis M Botana
Journal:  Toxins (Basel)       Date:  2015-03-27       Impact factor: 4.546

3.  Yessotoxin, a Marine Toxin, Exhibits Anti-Allergic and Anti-Tumoural Activities Inhibiting Melanoma Tumour Growth in a Preclinical Model.

Authors:  Araceli Tobío; Amparo Alfonso; Iris Madera-Salcedo; Luis M Botana; Ulrich Blank
Journal:  PLoS One       Date:  2016-12-14       Impact factor: 3.240

Review 4.  Alzheimer's Disease and Toxins Produced by Marine Dinoflagellates: An Issue to Explore.

Authors:  Maria João Botelho; Jelena Milinovic; Narcisa M Bandarra; Carlos Vale
Journal:  Mar Drugs       Date:  2022-04-02       Impact factor: 6.085

5.  Comparative analysis of the cytotoxic effects of okadaic acid-group toxins on human intestinal cell lines.

Authors:  Pierre-Jean Ferron; Kevin Hogeveen; Valérie Fessard; Ludovic Le Hégarat
Journal:  Mar Drugs       Date:  2014-08-21       Impact factor: 5.118

6.  Synthesis of the ABCDEF and FGHI ring system of yessotoxin and adriatoxin.

Authors:  Yuan Zhang; Jon D Rainier
Journal:  J Antibiot (Tokyo)       Date:  2016-03-09       Impact factor: 2.649

Review 7.  Yessotoxin, a Promising Therapeutic Tool.

Authors:  Amparo Alfonso; Mercedes R Vieytes; Luis M Botana
Journal:  Mar Drugs       Date:  2016-01-28       Impact factor: 5.118

Review 8.  Mixtures of Lipophilic Phycotoxins: Exposure Data and Toxicological Assessment.

Authors:  Jimmy Alarcan; Ronel Biré; Ludovic Le Hégarat; Valérie Fessard
Journal:  Mar Drugs       Date:  2018-01-31       Impact factor: 5.118

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.